Ultimate Control for Immunohistochemistry and in situ Hybridisation

AMSBIO announces the launch of CellMax™

Written byAMSbio
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

AMSBIO announces the launch of CellMax™ - a new range of high quality, consistent and affordable cell line FFPE slides.

Made using a patent-pending process, CellMax™ Cell Pellet Slides have a highly consistent density and homogeneity across the entire cell pellet block that ensures you get accurate results time after time. Cells are harvested by a proprietary trypsin-free method preserving cell surface antigens and inflicting minimal physical damage that could lead to a loss of biomarkers.

CellMax™ slides produce accurate and reproducible results for immunohistochemistry (IHC) providing confidence in antibody performance during IHC analysis. Using CellMax™ both morphological and biological molecules, including protein and nucleic acid targets, are well preserved offering a reference standard for tissue quality during in situ hybridisation (ISH) analysis.

CellMax™ slides are a renewable source of positive and negative controls, derived from 50 tumour cell lines, suitable for assay development and routine analysis.

Founded in 1987, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies